Scott Solomon | BiotechTV

top of page

Sep 1, 2024

Dr. Scott Solomon, PI of Bayer's FINEARTS-HF study of KERENDIA, discusses using this non-steroidal MRA in heart failure at the ESC Congress

He describes the results of this study, which tested KERENDIA in patients with mildly reduced or preserved ejection fraction.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Savills' Life Sciences Overview

bottom of page

Dr. Scott Solomon, PI of Bayer's FINEARTS-HF study of KERENDIA, discusses using this non-steroidal MRA in heart failure at the ESC Congress

Follow BiotechTV

Sponsors

Sponsor Spotlight